/ /

LATEST

Battle of the brandsRealSelf dips into its data to reveal which minimally invasive aesthetic products and technologies have captured consumer interest... and which are going to create competition in 2017.
A checklist to practice what you preach
A checklist to practice what you preachIt’s a lot simpler to help your patients if you can fully stand behind what you’re suggesting. Can you add any of these simple tips to your to-do list this week?
A new year, new era in dermatology, new magazineThe word of the moment is "new!" We have a new year, a new president, we are looking at the possibility of another new organizational structure in medicine, and we are working on a new look here at Dermatology Times.
Protocol for injecting fillers gives more predictable resultsPartitioning the face into different units and injecting filler in specific locations is a method to attaining a rejuvenated face that looks relaxed and natural.
New neurotoxin on the block starts phase 3 trialsThe injectable neurotoxin drug candidate daxibotulinumtoxinA for injection (RT002, Revance Therapeutics) started phase 3 SAKURA trials in December 2016
Keloid care and insurers – will they or won’t they pay?Insurers tend to think of keloids as a cosmetic issue so they have a wide range of standards covering reimbursement for care and treatments. Practitioners must fully document the medical necessity of the care they provide and then code the conditions and treatments correctly to maximize their chance for reimbursement.
Coding 2017 and beyondRecent Medicare changes include the apparent disappearance of consultation codes, the addition of site-specific soft-tissue excision codes, and increasing pressure from overseers and auditors, says an expert.
RF microneedling applicationsOne dermatologists describes her success with radiofreqency microneedling to treat acne and acne scarring.
The Skinny on fat reduction, cellulite devicesFresh after her presentations on fat reduction and cellulite treatment devices at ASDS, Sue Ellen Cox, M.D., offers unplugged advice about today’s technologies.
New era looming MCC treatmentImmune checkpoint inhibitors are providing rapid and durable responses for patients with metastatic Merkel cell carcinoma.

Poll

View Results